MK

Meenu Katoch

Active Director Director DIN 10410300
DIN 10410300 First appointment Nov 2023 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Nov 2023
Shareholding value Locked Premium profile

About Meenu Katoch

Meenu Katoch has 2 years in corporate governance. Holds Director role. Currently with 1 company, including Mrb Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 10410300
Primary Designation Director
First Appointment 30 Nov 2023
Oldest Company Age 2 yrs

Current companies

Company Designation Appointment Founded Status
Mrb Pharma Private Limited U47721HR2023PTC116882
Director 30 Nov 2023 2023 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Mrb Pharma Private Limited
Premium access

Shareholding and investment profile for Meenu Katoch

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Meenu Katoch

Meenu Katoch has 2 years in corporate governance. Holds Director role. Currently with 1 company, including Mrb Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Meenu Katoch is associated with 1 company as Director.

Meenu Katoch has expertise in General Business.

Meenu Katoch has 2 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available